John Wahren

Direttore Tecnico/Scientifico/R&S presso Creative Peptides Sweden AB

Health Technology

Consumer Services

Profilo

John Wahren was the founder of Cebix, Inc. which was founded in 2008, where he held the title of Director & Chief Scientific Officer from 2010 to 2014.
He is currently employed as an Emeritus Professor-Clinical Physiology at Karolinska Institutet and as Chief Scientific Officer at Creative Peptides Sweden AB.
Dr. Wahren's former position was as a Professor at the University of Lausanne in 1984.
He obtained his doctorate degree from Karolinska Institutet.

Posizioni attive di John Wahren

Società	Posizione	Inizio
Creative Peptides Sweden AB Creative Peptides Sweden AB Pharmaceuticals: MajorHealth Technology Creative Peptides Sweden AB develops and manufactures drugs. The company discovers and develops biopharmaceutical drugs to treat complications of Type 1 diabetes. It was founded in 1996 and is headquartered in Stockholm, Sweden.	Direttore Tecnico/Scientifico/R&S	-
Karolinska Institutet	Corporate Officer/Principal	24/06/2009

Tutte le posizioni attive di John Wahren

Precedenti posizioni note di John Wahren

Società	Posizione	Fine
University of Lausanne	Corporate Officer/Principal	01/01/1984
Cebix, Inc. Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA.	Fondatore	-

Vedi nel dettaglio l'esperienza di John Wahren

Formazione di John Wahren

Karolinska Institutet

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John Wahren

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Creative Peptides Sweden AB Creative Peptides Sweden AB Pharmaceuticals: MajorHealth Technology Creative Peptides Sweden AB develops and manufactures drugs. The company discovers and develops biopharmaceutical drugs to treat complications of Type 1 diabetes. It was founded in 1996 and is headquartered in Stockholm, Sweden.	Health Technology
Cebix, Inc. Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA.	Health Technology